4D pharma gets green light for phase I clinical trial of Parkinson's disease - Duncan Peyton, CEO, 4D Pharma 00:00:00

Share On Facebook Share On Twitter

4D pharma PLC CEO Duncan Peyton tells Proactive the group has received the green light for a first-in-human trial of its Parkinson’s disease candidates in the US.

Recent Videos